Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Asieris, Biosyngen, Dizal, Eisai, Gan & Lee, Immvira, Immutep, Innovent, Insilico.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Apollomics, Astrazeneca, Biogen, Hightide, Innovent, QL Biopharmaceutical, Ractigen, Telix.